Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mologen

Mologen?uq=UG6efJS6
PUBLIC STATUS
51-60 EMPLOYEES
MGNK STOCK SYMBOL
$3.57 SHARE PRICE (As of Thursday Closing)
Description

Provider of a self-developed platform for immunotherapies and drugs, designed to treat cancer and serious infectious diseases. The company's immunotherapies and drugs are based on proprietary platform technologies which engages in research and development of innovative DNA-based medicines in the fields of oncology and infectious diseases, enabling cancer patients to treat severe parasitic diseases.

Website
Ownership Status
Publicly Held
Financing Status
Formerly Angel backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
BER
Primary Office
  • Fabeckstraße 30
  • 14195 Berlin
  • Germany

+49 030 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mologen’s full profile, request a free trial.

Mologen Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$3.39 - $16.96 $31.5M $3.40 -$2.18 110.40 9.3M

Mologen Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 28,726 80,977 27,028 81,871
Revenue 53 82 43
EBITDA (15,154) (21,042) (22,761) (22,650)
Net Income (15,952) (21,744) (23,232) (22,781)
Total Assets 9,290 9,724 22,466 28,858
Total Debt 18 11 3 9
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Mologen Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Mologen‘s full profile, request access.

Request full access to PitchBook

Mologen Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Mologen‘s full profile, request access.

Request full access to PitchBook

Mologen Executive Team (5)

Name Title Board
Seat
Contact
Info
Ignacio Faus Ph.D Chief Executive Officer
Walter Miller Chief Financial Officer & Board Member
Burghardt Wittig Ph.D Co-Founder
Matthias Baumann Chief Medical Officer

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »

Mologen Board Members (6)

Name Representing Role Since Contact
Info
Mariola Söhngen Ph.D Mologen Board Member 000 0000
Oliver Krautscheid Self Board Member 000 0000
Stefan Manth Ph.D Mologen Non-Executive Director & Deputy Chairman, Scientific Advisory Board Member 000 0000
Susanne Klimek Self Board Member 000 0000
Walter Miller Mologen Chief Financial Officer & Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »